HPV vaccine coverage among men who have sex with men - National HIV Behavioral Surveillance System, United States, 2011

Elissa Meites*, Lauri E. Markowitz, Gabriela Paz-Bailey, Alexandra M. Oster, Jianglan White, Jeff Todd, Greg Bautista, Colin Flynn, Danielle German, Maura Miminos, Rose Doherty, Chris Wittke, Nikhil Prachand, Nanette Benbow, Sharon Melville, Shane Sheu, Alicia Novoa, Mark Thrun, Alia Al-Tayyib, Ralph WilmothVivian Griffin, Emily Higgins, Karen MacMaster, Marcia Wolverton, Hafeez Rehman, Paige Padgett, Trista Bingham, Ekow Kwa Sey, Marlene LaLota, Lisa Metsch, David Forrest, Bridget J. Anderson, Carol Ann Watson, Lou Smith, De Ann Gruber, William T. Robinson, Narquis Barak, Alan Neai-gus, Kathleen H. Reilly, Travis Wendel, Barbara Bolden, Afework Wogayehu, Henry Godette, Kathleen A. Brady, Andrea Sifferman, Vanessa Miguelino-Keasling, Al Velasco, Veronica Tovar, H. Fisher Raymond, Sandra Miranda De León, for the NHBS Study Group

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Abstract

Men who have sex with men (MSM) are at high risk for disease associated with human papillomavirus (HPV). In late 2011, HPV vaccine was recommended for males through age 21 and MSM through age 26. Using data from the 2011 National HIV Behavioral Surveillance System, we assessed self-reported HPV vaccine uptake among MSM, using multivariate analysis to calculate adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs). Among 3221 MSM aged 18-26, 157 (4.9%) reported ≥1 vaccine dose. Uptake was higher among men who visited a healthcare provider (aPR 2.3, CI: 1.2-4.2), disclosed same-sex sexual attraction/behavior to a provider (aPR 2.1, CI: 1.3-3.3), reported a positive HIV test (aPR 2.2, CI: 1.5-3.2), or received hepatitis vaccine (aPR 3.9, CI: 2.4-6.4). Of 3064 unvaccinated MSM, 2326 (75.9%) had visited a healthcare provider within 1 year. These national data on HPV vaccine uptake among MSM provide a baseline as vaccination recommendations are implemented.

Original languageEnglish (US)
Pages (from-to)6356-6359
Number of pages4
JournalVaccine
Volume32
Issue number48
DOIs
StatePublished - Nov 12 2014

Funding

This study was funded by CDC. The authors thank all of the 2011 NHBS participants, Nevin Krishna, Brooke Hoots, and Teresa Finlayson (Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, CDC) for their assistance.

Keywords

  • Human papillomavirus (HPV)
  • Men who have sex with men (MSM)
  • Vaccine uptake

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • General Immunology and Microbiology
  • Infectious Diseases
  • Molecular Medicine
  • General Veterinary

Fingerprint

Dive into the research topics of 'HPV vaccine coverage among men who have sex with men - National HIV Behavioral Surveillance System, United States, 2011'. Together they form a unique fingerprint.

Cite this